Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - GCC

The Digestives & Intestinal Remedies market market in GCC is projected to generate a revenue of US$259.50m in 2024.
It is anticipated to exhibit an annual growth rate of 2.20% (CAGR 2024-2029).
When compared to other countries worldwide, in China leads the market with a revenue of US$4,408.00m in 2024.
In terms of per capita income, each individual in GCC is expected to contribute US$4.30 towards the revenue in 2024.
In the GCC, there is a growing demand for natural and herbal digestive remedies, as consumers seek alternative solutions for their digestive health.

Key regions: Brazil, India, United Kingdom, Germany, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Digestives & Intestinal Remedies market in GCC is experiencing steady growth due to changing customer preferences and an increase in digestive health issues in the region.

Customer preferences: Customers in the GCC region are becoming more health-conscious and are seeking products that can help improve their digestive health. This shift in preferences is driven by a growing awareness of the importance of maintaining a healthy gut and the impact it has on overall well-being. As a result, there is a growing demand for digestive and intestinal remedies in the market.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in GCC is the increasing popularity of natural and herbal remedies. Customers are increasingly opting for products that are made from natural ingredients and do not contain any artificial additives or preservatives. This trend is driven by a desire for more holistic and sustainable solutions to digestive health issues.Another trend in the market is the rise of probiotics and prebiotics. Probiotics are live bacteria that promote a healthy gut by balancing the intestinal flora, while prebiotics are non-digestible fibers that serve as food for the beneficial bacteria in the gut. These products are gaining popularity as they are believed to improve digestion and boost the immune system.

Local special circumstances: The GCC region has a high prevalence of digestive health issues, which is driving the demand for digestive and intestinal remedies. Factors such as a sedentary lifestyle, unhealthy eating habits, and stress contribute to the increasing incidence of digestive disorders in the population. This creates a favorable market environment for companies operating in the Digestives & Intestinal Remedies sector.

Underlying macroeconomic factors: The growing population and rising disposable incomes in the GCC region are contributing to the growth of the Digestives & Intestinal Remedies market. As people have more money to spend on healthcare and wellness products, they are willing to invest in products that can improve their digestive health. Additionally, the increasing urbanization and Westernization of lifestyle in the region are also driving the demand for digestive and intestinal remedies.In conclusion, the Digestives & Intestinal Remedies market in GCC is witnessing growth due to changing customer preferences, increasing awareness of digestive health, and the high prevalence of digestive disorders in the region. The market is characterized by a shift towards natural and herbal remedies, as well as the growing popularity of probiotics and prebiotics. The favorable market conditions, driven by the underlying macroeconomic factors, are expected to continue supporting the growth of the market in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.